Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
帕奈替尼可抑制多克隆耐药性 KIT 癌蛋白,并对接受过大量治疗的胃肠道间质瘤 (GIST) 患者显示出治疗潜力
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-14-1397
Andrew P Garner #, Joseph M Gozgit #, Rana Anjum, Sadanand Vodala, Alexa Schrock, Tianjun Zhou, Cesar Serrano, Grant Eilers, Meijun Zhu, Julia Ketzer, Scott Wardwell, Yaoyu Ning, Youngchul Song, Anna Kohlmann, Frank Wang, Tim Clackson, Michael C Heinrich, Jonathan A Fletcher, Sebastian Bauer, Victor